期刊
CLINICAL CANCER RESEARCH
卷 21, 期 14, 页码 3121-3130出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-14-1189
关键词
-
类别
资金
- Altman Goldstein Discovery Fellowship
- Ovarian Cancer Research Fund
- Foundation for Women's Cancer
- Cancer Prevention Research Institute of Texas (CPRIT) [RP101502, RP101489, RP110595]
- NIH [U54CA151668, P50CA083639, CA109298, P50CA098258, UH2TR000943, CA016672, U54CA96300, U54CA96297]
- CPRIT [RP110595, RP120214]
- Ovarian Cancer Research Fund Program Project Development Grant
- U.S. Department of Defense [OC120547, OC093416]
- Betty Ann Asche Murray Distinguished Professorship
- RGK Foundation
- Gilder Foundation
- Judi A. Rees Ovarian Cancer Research Fund
- Chapman Foundation
- Meyer and Ida Gordon Foundation
- Blanton-Davis Ovarian Cancer Research Program
Recent advances in nanotechnology have established its importance in several areas including medicine. The myriad of applications in oncology range from detection and diagnosis to drug delivery and treatment. Although nanotechnology has attracted a lot of attention, the practical application of nanotechnology to clinical cancer care is still in its infancy. This review summarizes the role that nanotechnology has played in improving cancer therapy, its potential for affecting all aspects of cancer care, and the challenges that must be overcome to realize its full promise. (C) 2015 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据